Grantham, Mayo, Van Otterloo & Co (GMO)’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-4,164
Closed -$329K – 668
2024
Q4
$329K Hold
4,164
– – ﹤0.01% 529
2024
Q3
$357K Buy
4,164
+368
+10% +$27.5K ﹤0.01% 511
2024
Q2
$260K Buy
+3,796
New +$250K ﹤0.01% 492
2023
Q3
– Sell
-28,998
Closed -$1.17M – 675
2023
Q2
$1.17M Buy
28,998
+1,198
+4% +$51.7K 0.01% 478
2023
Q1
$1.29M Buy
+27,800
New +$1.32M 0.01% 458

Other funds holding SLVM

Grantham, Mayo, Van Otterloo & Co (GMO)'s SLVM Position: Q1 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Sylvamo (SLVM) in Q1 2025, closing a stake of 4,164 shares — an estimated $329K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SLVM in Q1 2023 and held it in 5 quarters. The position peaked at $1.29M in Q1 2023. 387 funds tracked by Wall St. Rank hold SLVM as of Q1 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Sylvamo position as of Q1 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,164 Sylvamo shares in Q1 2025, an estimated $329K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Sylvamo in Q1 2023 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Sylvamo position peaked at $1.29M in Q1 2023.
  • 387 funds tracked by Wall St. Rank held Sylvamo as of Q1 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2025, filed 14 May 2025.